VP Sales, Pharmaceutical Partnerships; Oncology

VP Sales, Pharmaceutical Partnerships (US)

Sector: Digital Health | Oncology

Location: United States (remote with travel)

Client Overview (Confidential)

Our client is a rapidly scaling, highly disruptive digital health company specializing in oncology
, with record growth and active international expansion across the EU and US. The platform sits at the intersection of cancer care delivery, real-world data, and pharmaceutical collaboration
, creating measurable value for patients, providers, and life sciences partners.

To support its next phase of growth, the company is strengthening its senior commercial leadership in the United States.

The VP Sales, Pharmaceutical Partnerships will own and scale the company’s commercial relationships with pharmaceutical and life sciences partners in the US
. This role is central to revenue growth and strategic positioning, working closely with senior stakeholders across pharma, medical affairs, commercial, and market access functions.

This is a hands-on, externally facing leadership role
, suited to a senior commercial operator with deep credibility in oncology-focused pharma partnerships.

• Lead and scale US pharmaceutical partnership sales
  , from opportunity identification through deal close and expansion
• Build and manage senior relationships across oncology-focused pharmaceutical and biotech companies
• Position the company’s platform as a strategic partner across real-world evidence, patient support, engagement, and outcomes-driven initiatives
• Own revenue targets and pipeline development for pharma partnerships
• Collaborate closely with product, medical, and data teams to shape partnership offerings
• Represent the company with credibility at industry events and executive-level discussions

• Senior sales or business development leader from oncology-focused pharma services, digital health, health tech, or life sciences platforms
• Demonstrated success selling complex, high-value partnerships into pharmaceutical companies
• Deep understanding of oncology drug development, commercialization, and stakeholder dynamics
• Comfortable operating in a fast-scaling, entrepreneurial environment
• Strong executive presence and ability to sell strategically at C-suite and VP level
• US-based, with willingness to travel

• Direct ownership of a strategic revenue pillar
• Exposure to senior pharma decision-makers and long-term partnership upside
• High-growth platform with proven traction and international momentum